reason report
lower estim reflect slower market growth pt
bottom line conjunct just-publish tavr
transcathet aortic valv replac survey link
lower out-year ew estim reflect
believ may slower market growth least near-term
lower revenu estim
sale estim move
lower estim reflect conservat around
market growth -- particularli within intermedi low risk patient
popul -- vs prior expect project slightli slower
 tavr market growth vs previous
line consensu still low-double-digit volum
growth suggest tavr survey head given
tavr survey suggest sequenti volum declin
forese meaning sale upsid consensu even
estim y/i sequenti
reiter mp pt price target
previous appli price-to-earnings multipl ep
estim pt assum multipl contract current
ep still large-cap group averag
prior multipl given believ investor want
ew head low risk data american colleg
cardiolog march like provid downsid support multipl
also continu think ew market-lead posit highli
under-penetrated total address market justifi compani
premium valuat rel rest large-cap med-tech group
net debt total capit
price-to-earnings lt ep growth
medic suppli devic
ep
year price history/av daili volume mil ew
compani inform svb leerink llc research
revenu mm non-gaap dilut adjust ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
rate edward lifesci nyse ew share market perform
price target edward current market leader tavr transcathet aortic
valv replac market intern continu believ tavr
repres one excit new med-tech market high-teen higher
project market compound-annual-growth-rate time-frame base estim sens
ramp less sick patient popul current intermedi risk potenti
low risk beyond might occur slower pace already-elev investor
expect continu believ intermedi risk indic repres massiv
increment market opportun estim intermedi risk doubl
address patient popul also believ ramp patient slower
saw inoper high risk given linger question around tavr durabl
longer term need seemingli intens market develop effort drive
referr particularli younger less sick portion intermedi risk patient popul
potenti increas surgeon pushback less sick patient popul
heart member ramp effort preserv surgic busi
ultim believ global tavr market exceed new indic come
on-line low risk eventu asymptomat ew guidanc given
view low risk ramp like slower seen high risk
intermedi risk patient popul near-to-medium term ew still beat
rais stori base earli read intermedi risk adopt ramp think beat
next month may smaller tougher come
last two year particularli light competit launch addit steadier intermedi
risk ramp vs step function chang growth street seem expect share current
trade earn becom increasingli difficult argu meaning
multipl expans
price target previous appli price-to-earnings multipl
ep estim pt assum multipl contract current
ep still large-cap group averag also think ew
market-lead posit highli under-penetrated total address market justifi
compani premium valuat rel rest large-cap med-tech group
risk includ inflect point intermedi risk adopt ramp neg competit
clinic data and/or competit launch delay faster-than-expect low risk
asymptomat trial ramp earlier-than-expect cardiaq feasibl trial re-start
dollar million except per share data
good sold
research develop expens
pre-tax incom continu oper
incom continu oper
sg sale
 sale
oper expens sale
compani report svb leerink estim
